IT1203657B - Impiego in terapia di n-(dietilamminoetil)-2-metossi-5-metilsolfonil-benzammide e medicamento che la contiene - Google Patents

Impiego in terapia di n-(dietilamminoetil)-2-metossi-5-metilsolfonil-benzammide e medicamento che la contiene

Info

Publication number
IT1203657B
IT1203657B IT48506/83A IT4850683A IT1203657B IT 1203657 B IT1203657 B IT 1203657B IT 48506/83 A IT48506/83 A IT 48506/83A IT 4850683 A IT4850683 A IT 4850683A IT 1203657 B IT1203657 B IT 1203657B
Authority
IT
Italy
Prior art keywords
methoxy
benzamide
dietylaminoethyl
methylsulphonyl
medication
Prior art date
Application number
IT48506/83A
Other languages
English (en)
Italian (it)
Other versions
IT8348506A0 (it
Inventor
Denis Besancon
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of IT8348506A0 publication Critical patent/IT8348506A0/it
Application granted granted Critical
Publication of IT1203657B publication Critical patent/IT1203657B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
IT48506/83A 1982-06-17 1983-06-15 Impiego in terapia di n-(dietilamminoetil)-2-metossi-5-metilsolfonil-benzammide e medicamento che la contiene IT1203657B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8210565A FR2528702A1 (fr) 1982-06-17 1982-06-17 Application du n-(diethylaminoethyl) 2-methoxy-5-methylsulfonyl benzamide dans l'inhibition de la tryptophane pyrrolase

Publications (2)

Publication Number Publication Date
IT8348506A0 IT8348506A0 (it) 1983-06-15
IT1203657B true IT1203657B (it) 1989-02-15

Family

ID=9275096

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48506/83A IT1203657B (it) 1982-06-17 1983-06-15 Impiego in terapia di n-(dietilamminoetil)-2-metossi-5-metilsolfonil-benzammide e medicamento che la contiene

Country Status (8)

Country Link
US (1) US4485115A (enExample)
EP (1) EP0099775B1 (enExample)
JP (1) JPS5916823A (enExample)
AT (1) ATE22800T1 (enExample)
DE (2) DE3320187A1 (enExample)
FR (1) FR2528702A1 (enExample)
HK (1) HK56189A (enExample)
IT (1) IT1203657B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6245371A (ja) * 1985-08-24 1987-02-27 Toyota Motor Corp 車両ボデ−外板の塗装方法およびその装置
JPH0767544B2 (ja) * 1986-12-27 1995-07-26 トヨタ自動車株式会社 回転霧化静電塗装装置
EP0520325A1 (de) * 1991-06-28 1992-12-30 F.Hoffmann-La Roche & Co. Aktiengesellschaft Verwendung von Monoaminoxidase-B-Hemmern zur Verhütung und Behandlung von Entzugserscheinungen nach Alkohol- und Drogenmissbrauch
EP1380292A1 (de) * 2002-07-03 2004-01-14 Mewicon med. wiss. Beratung GmbH Tiaprid zur Behandlung von Depressionen
US20040224031A1 (en) * 2003-05-06 2004-11-11 Antonio Zorzano Olarte Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus
CN119384278A (zh) * 2022-06-10 2025-01-28 上海日馨医药科技股份有限公司 治疗精神类疾病的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791677A (fr) * 1972-07-19 1973-03-16 Renfag Sa Procede de preparation de n-(diethylaminoethyl)-2- methoxy-5-methylsulfonyl-benzamide
FR2243187B1 (enExample) * 1973-09-10 1978-12-29 Ile De France
FR2305176A1 (fr) * 1975-03-28 1976-10-22 Ile De France Nouveau medicament a base de n-(diethylaminoethyl) 2-methoxy-5-methyl-sulfonyl benzamide
JPS5283621A (en) * 1976-01-01 1977-07-12 Yamanouchi Pharmaceut Co Ltd N-benzyl-n, -benzylethyldiamine derivative

Also Published As

Publication number Publication date
JPS5916823A (ja) 1984-01-28
EP0099775A1 (fr) 1984-02-01
DE3320187A1 (de) 1983-12-22
ATE22800T1 (de) 1986-11-15
HK56189A (en) 1989-07-21
IT8348506A0 (it) 1983-06-15
DE3366834D1 (en) 1986-11-20
FR2528702A1 (fr) 1983-12-23
US4485115A (en) 1984-11-27
FR2528702B3 (enExample) 1985-04-19
JPH0344050B2 (enExample) 1991-07-04
EP0099775B1 (fr) 1986-10-15

Similar Documents

Publication Publication Date Title
ATE32730T1 (de) Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
FI881305A7 (fi) Ihmisen virusinfektioiden käsittely dsRNA:n ja virusinhibiittorien yhdistelmällä.
FI844510A0 (fi) Ensym-resistenta immunsystemet modulerande peptider.
SE9701161D0 (sv) New use I
ES435273A1 (es) Un procedimiento de preparacion de n-(1-bencil-pirrolidi- nil-2-alcohil) -benzamidas sustituidas.
IT1175306B (it) Impiego di diidropiridine in prodotti medicinali dotati di azione salidiuretica
IT1203657B (it) Impiego in terapia di n-(dietilamminoetil)-2-metossi-5-metilsolfonil-benzammide e medicamento che la contiene
IT1125479B (it) Trattamento del gas di spurgo nella sintesi della ammoniaca
IT8548206A0 (it) Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto
ATE81462T1 (de) Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
IT1150396B (it) Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
SE7708176L (sv) Bensamidforeningar
IT965295B (it) Procedimento per il trattamento di fibre sintetiche e fibre cosi trattate
DK325387A (da) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid samt dets fremstilling og anvendelse
DK491984D0 (da) Diarylindan-1,3-dioner, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK139685A (da) Liposomer med inhalative allergener til behandling af allergier, fremgangsmaade til deres fremstilling og laegemidler indeholdende disseliposomer
JO1120B1 (en) N-(1-allye-2-pyrrolidiny-methyl)2methoxy-4-amino-5-methylsulfamoyl benzamide, its method of oreperation and its use as a medicament
ATE69549T1 (de) Erzeugnisse, enthaltend gallopamil und prazosin.
DK222988A (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
DE3772764D1 (de) Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl)-methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung.
FR2584605B1 (fr) Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
IT8248421A0 (it) Impiego di l-carnitina e di acil-lcarnitine nel trattamento terapeutico delle neoplasie
DE3586795D1 (de) Absorptionsverbesserer fuer proteine.